CIEA NOG mouse®

Taconic Terms and Conditions
CIEA NOG ® Constitutive Knockout / Spontaneous Mutant Mouse Model
  • Live
  • Mouse
  • Male & Female Available
  • Albino
  • Available for direct purchase by CRO
Model No.NomenclatureGenotype
NOG-FNOD.Cg-Prkdcscid Il2rgtm1Sug/JicTacsp/sp;ko/ko
NOG-MNOD.Cg-Prkdcscid Il2rgtm1Sug/JicTacsp/sp;ko/y
Taconic Terms and Conditions
View:
Select One

Overview

Nomenclature: NOD.Cg-Prkdcscid Il2rgtm1Sug/JicTac

 

The first and most versatile severely immunodeficient mouse model 

  • Immunodeficient model lacking mature T, B, and NK cells
  • Displays reduced complement activity
  • Has dysfunctional macrophages and dendritic cells
  • Displays no leakiness of T and B cells with increasing age
  • Very low incidence of lymphoma (unlike NOD scid model)
  • Does not develop diabetes
  • Excellent model for a variety of xenograft and human cell engraftment studies
  • Applications in research involving Cancer, Infectious Disease, Immunology, Regenerative Medicine, Humanization, Autoimmune Disease, Immunotherapy Vaccine, GvHD/Transplantation, Hematopoiesis, Oncology, Inflammation/Allergy, and Safety Assessment
  • The Il2rg gene is sex-linked

Availability

Available now*
*Please note that advanced order placement is encouraged for male mice. Ordering 4 or more weeks prior to the desired shipping date is recommended when requesting males older than 3-weeks of age.

Origin

The CIEA NOG mouse® was developed by Mamoru Ito of the Central Institute for Experimental Animals (CIEA) in Japan. The Prkdc scid mutation was identified by Mel Bosma of the Fox Chase Cancer Center in a C.B-17 congenic mouse population. This mutation was backcrossed onto the NOD/ShiJic strain at CIEA for at least eight generations. The Il2rg targeted mutation was developed by Dr. Kazuo Sugamura of Tohoku University by targeting the gene in ES cells derived from a 129 strain. Portions of exons 7 and 8 were replaced with a neo cassette. Targeted ES cells were injected into C57BL/6 blastocysts. Resultant chimeras were backcrossed onto the C57BL/6JJic background for at least eight generations. The CIEA NOG mouse® was developed by backcrossing the C57BL/6JJic-Il2rg line to the NOD/ShiJic-Prkdc scid line for a total of eight generations. Taconic received stock in 2006, and the line was derived through embryo transfer. The CIEA NOG mouse® colony was refreshed in 2011 and 2015 via rederivation of new stock using donors/donor material sourced from the CIEA NOG mouse® foundation colony at CIEA. The mice are maintained by breeding females homozygous for both the Prkdc scid and Il2rg mutant alleles with males that are homozygous for the Prkdc scid allele and hemizygous for the Il2rg mutant allele.

Webinar On-Demand

ON-DEMAND WEBINAR | Humanized Mice in Preclinical Immuno-Oncology - Part I

Watch Now

Webinar On-Demand

ON-DEMAND WEBINAR | An Introduction to Humanized Immune System (HIS) Mice - Part I of series

Watch Now

White Paper

Humanized Mouse Models for Drug Discovery: The NOG Portfolio | WHITE PAPER
Download
wp

2025 Pricing Guide Now Available

Get your Taconic Biosciences 2025 Pricing Guide today. Personalized, customizable, links to up-to-date health reports, and additional information on Taconic's products and services.

Get Your Guide
Pricing Guide
Smart Select Program

Trial an Animal Model for Quality & Compatibility Assurance

As longtime facilitators of animal-based research, we understand the importance of aligning your project goals and procurement priorities to support advancements in your research. 

  • Evaluate a specific model strain, before making any financial investment
  • Request up to 20 animals from one of the strains listed below, to test for quality, consistency, and suitability for your experimental purpose
  • Enjoy free ground shipping, where applicable (see table for more details)*

Taconic is committed to protecting and respecting your privacy. Occasionally, we would like to contact you about our products and services. If you consent to us contacting you, please tick the check box:

You may unsubscribe from these communications at any time. For more information on how to unsubscribe and our privacy practices, please review our Privacy Policy.

By clicking the button below, you consent to allow Taconic to store and process the personal information submitted in this form to provide you the content requested.

Hear From our Scientists